BlackRock Inc. raised its holdings in shares of Orthopediatrics Corp (NASDAQ:KIDS) by 74.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 341,196 shares of the company’s stock after acquiring an additional 146,115 shares during the quarter. BlackRock Inc. owned approximately 2.67% of Orthopediatrics worth $9,090,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also bought and sold shares of the company. Sei Investments Co. purchased a new stake in shares of Orthopediatrics during the second quarter worth about $126,000. Paradigm Capital Management Inc. NY purchased a new stake in shares of Orthopediatrics during the second quarter worth about $280,000. Millennium Management LLC purchased a new stake in shares of Orthopediatrics during the first quarter worth about $172,000. Schwab Charles Investment Management Inc. purchased a new stake in shares of Orthopediatrics during the second quarter worth about $344,000. Finally, Stifel Financial Corp purchased a new stake in shares of Orthopediatrics during the first quarter worth about $196,000. Hedge funds and other institutional investors own 40.22% of the company’s stock.
Shares of NASDAQ KIDS opened at $30.65 on Monday. The company has a quick ratio of 3.61, a current ratio of 5.67 and a debt-to-equity ratio of 0.62. Orthopediatrics Corp has a 12 month low of $14.00 and a 12 month high of $39.81. The stock has a market cap of $392.66 million and a PE ratio of -5.38.
Orthopediatrics (NASDAQ:KIDS) last released its earnings results on Wednesday, October 31st. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.03). Orthopediatrics had a negative return on equity of 65.26% and a negative net margin of 55.97%. The company had revenue of $15.82 million during the quarter, compared to analyst estimates of $15.19 million. During the same period in the prior year, the business posted ($1.70) earnings per share. Orthopediatrics’s revenue was up 27.8% on a year-over-year basis. On average, research analysts predict that Orthopediatrics Corp will post -0.98 earnings per share for the current fiscal year.
In related news, General Counsel Daniel J. Gerritzen sold 9,525 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $33.73, for a total value of $321,278.25. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Kevin Unger sold 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $33.22, for a total transaction of $33,220.00. The disclosure for this sale can be found here. 46.10% of the stock is currently owned by company insiders.
KIDS has been the subject of a number of recent research reports. BidaskClub downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a report on Wednesday, August 8th. Zacks Investment Research upgraded shares of Orthopediatrics from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a report on Wednesday, October 10th. Finally, ValuEngine upgraded shares of Orthopediatrics from a “hold” rating to a “buy” rating in a report on Thursday, August 2nd. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. Orthopediatrics has a consensus rating of “Buy” and an average target price of $29.25.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Further Reading: Why do earnings reports matter?
Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthopediatrics Corp (NASDAQ:KIDS).
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.